Stock listing
NASDAQ:CYT Cyteir Therapeutics Inc Stock
Follow Cyteir Therapeutics Inc into a list and get an email when it puts out news.
Last close · NASDAQ:CYT
$3.02 USD
Close on Mar 15, 2024 · No longer trades
- Lowest – highest close
- $1.18 – $21.86 USDSince Jun 18, 2021 · lowest Dec 20, 2022 · highest Aug 10, 2021
Delisted NASDAQ:CYT no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:CYT
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
Cyteir Therapeutics Inc on 6ix
- Calls
- 1 call with a replay · 1 with a transcript · latest Mar 16, 2022
- Decks
- 2 decks · latest Apr 26, 2022
Where Cyteir Therapeutics Inc is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:CYT · This page · Delisted | NASDAQ | United States | USD |
| OTC:CYTT · Delisted | OTC | United States | USD |
Events
| Call | When | Status |
|---|---|---|
| Cyteir Therapeutics (CYT) Q4 2021 Earnings Call | Wed, Mar 16, 2022 · 4:30 PM ET | Replay |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Day (April 2022) | Investor day | 39 slides | Apr 26, 2022 |
| 40th Annual J.P. Morgan Healthcare Conference (January 2022) | Conference | 24 slides | Jan 11, 2022 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Jean George Other companies: Disc Medicine, Inc. (Director · Feb 5, 2021 – Feb 5, 2021 · Past); Astria Therapeutics Inc (Director · Jun 24, 2015 – Jun 7, 2018 · Past); Calithera Biosciences, Inc. (Director · Oct 1, 2014 – Jun 11, 2021 · Past); Acceleron Pharma Inc (Director · Sep 18, 2013 – Jan 22, 2020 · Past); Portola Pharmaceuticals Inc (Director · May 21, 2013 – May 28, 2013 · Past); Zeltiq Aesthetics Inc (Director · Oct 18, 2011 – Jul 22, 2015 · Past) | Director · Jun 17, 2021 – Feb 14, 2024 · Past |
| Andrew Gengos Other companies: Immuneering Corporation (Chief Financial Officer and Treasurer · Since at least Jul 16, 2026); Turn Therapeutics Inc. (Director · Since at least Oct 7, 2025); Terns Pharmaceuticals, Inc. (Chief Financial Officer · Since at least Feb 24, 2025); LeonaBio, Inc. (CFO and Chief Business Officer · May 18, 2023 – Sep 3, 2024 · Past); Synlogic Inc (Chief Operating Officer · Oct 9, 2017 – Mar 14, 2018 · Past) | Chief Business Officer · Jun 17, 2021 – Feb 22, 2022 · Past |
| Jeffrey Humphrey Other companies: Lantheus Holdings, Inc. (Chief Medical Officer · May 28, 2024 – Jun 17, 2024 · Past); Dianthus Therapeutics, Inc. (Chief Medical Officer · Oct 1, 2021 – Aug 1, 2022 · Past); Constellation Pharmaceuticals Inc (Chief Medical Officer · Jun 22, 2020 – Jul 15, 2021 · Past) | Director · Dec 15, 2021 – Feb 3, 2023 · Past |
| Adam Veness Other companies: Dianthus Therapeutics, Inc. (General Counsel · Since at least Sep 11, 2023); Acceleron Pharma Inc (SVP, General Counsel and Sec. · Jan 4, 2021 – Nov 19, 2021 · Past) | General Counsel · Apr 25, 2022 – Feb 3, 2023 · Past |
| David G Gaiero Other companies: Imunon, Inc. (Chief Financial Officer · Jun 1, 2024 – Jun 1, 2024 · Past); Sensei Biotherapeutics, Inc. (Principal Financial Officer · May 10, 2024 – May 10, 2024 · Past) | Chief Financial Officer · Feb 3, 2023 – Feb 29, 2024 · Past |
| John F Thero | Director · Feb 8, 2024 – Feb 8, 2024 · Past |
| John Paul Secrist | Chief Scientific Officer · Jun 17, 2021 – Feb 22, 2022 · Past |
| Racquel Bracken | Director · Feb 3, 2023 – Feb 3, 2023 · Past |
| Timothy Romberger | Director · Jun 17, 2021 – Feb 3, 2023 · Past |
Log in to ask 6ix AI your own questions about Cyteir Therapeutics Inc.